Abstract: The present invention provides a method for manufacturing a compound represented by formula (I). With this method, provided are a method for manufacturing a 4-heteroaryl-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-5-carboxylic acid amide derivative; and an intermediate for this manufacturing method.

Abstract: The present invention provides a type I crystal of (E)-2-(7-trifluoromethyl-chroman-4-ylidene)-N-((7R)-7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide having excellent TRPV1 antagonistic activity, a drug and a pharmaceutical composition containing this crystal, and a method for producing the crystal. The present invention provides a type I crystal of (E)-2-(7-trifluoromethyl-chroman-4-ylidene)-N-((7R)-7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide that is excellent in at least one feature selected from the group consisting of storage stability, photostability and thermodynamic stability, that can be preferably obtained with industrially high reproducibility, yield and purity, and that is useful as a crystal of an active pharmaceutical ingredient.

Abstract: The present invention provides a method for manufacturing a compound represented by formula (I). With this method, provided are a method for manufacturing a 4-heteroaryl-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-5-carboxylic acid amide derivative; and an intermediate for this manufacturing method.

Abstract: The present invention provides a method for manufacturing a compound represented by formula (I). With this method, provided is a method for manufacturing a 4-substituted-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-5-carboxylic acid amide derivative; or an intermediate for this manufacturing method.

Abstract: The present invention provides a method for manufacturing a compound represented by formula (I). With this method, provided are a method for manufacturing a 4-heteroaryl-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-5-carboxylic acid amide derivative; and an intermediate for this manufacturing method.

Abstract: The present invention provides a method for manufacturing a compound represented by formula (I). With this method, provided are a method for manufacturing a 4-heteroaryl-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-5-carboxylic acid amide derivative; and an intermediate for this manufacturing method.

Abstract: The present invention provides a method for manufacturing a compound represented by formula (I). With this method, provided is a method for manufacturing a 4-substituted-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-5-carboxylic acid amide derivative; or an intermediate for this manufacturing method.

Abstract: An adapter is hooked to a ceiling socket located on the ceiling. Any one of first ring material and second ring material fixed to a chassis is interlocked to the adapter, to install the lighting apparatus on the ceiling. A circuit board is connected to a sensor board on which an illuminance sensor is mounted. The illuminance sensor outputs electric signals corresponding to the detected illuminance. A control unit adjusts the brightness of light emitted from a LED module, on the basis of the illuminance detected by the illuminance sensor. The illuminance sensor is fixed to the chassis in such a manner that it is inclined from a rotation axis about which the chassis is rotated.

Abstract: A compound represented by formula (I?): (wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R1 represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group, an NO2 group, or the like; R2 represents halogen, amino, a hydrocarbon group, an aromatic heterocyclic group, or an oxo group; X1 represents O, —NR3—, or —S(O)r-; X2 represents a methylene group, O, —NR3—, or —S(O)r-; Q? represents a heteroaryl group, a heteroarylalkyl group, a substituted aryl group, or an aralkyl group; Cycle moiety represents an aryl ring or a heteroaryl ring; and the wavy line represents an E-isomer or a Z-isomer), a salt of the compound, or a solvate of the compound or the salt. A pharmaceutical composition and a transient receptor potential type I (TRPV1) receptor antagonist each contain, as an active ingredient, at least one of the compound, a salt of the compound, and a solvate of the compound or the salt.

Abstract: A lighting apparatus includes a LED module provided at the central side of a chassis and a reflection sheet reflecting light emitted from the LED module. The LED module emits light to the outer edge portion of the chassis and then the light is reflected on the reflection sheet to perform illumination so that glare can be reduced. Then, the light emitted from the LED module is reflected on the reflection sheet in many directions so that a substantially uniform illuminated light with less illumination unevenness can be achieved. The LED module is not arranged at the outer edge portion of the chassis so that moment acting on the chassis can be reduced. Therefore, the deformation of chassis can be prevented.

Abstract: A compound represented by formula (I?): (wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R1 represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group, an NO2 group, or the like; R2 represents halogen, amino, a hydrocarbon group, an aromatic heterocyclic group, or an oxo group; X1 represents O, —NR3—, or —S(O)r-; X2 represents a methylene group, O, —NR3—, or —S(O)r-; Q? represents a heteroaryl group, a heteroarylalkyl group, a substituted aryl group, or an aralkyl group; Cycle moiety represents an aryl ring or a heteroaryl ring; and the wavy line represents an E-isomer or a Z-isomer), a salt of the compound, or a solvate of the compound or the salt. A pharmaceutical composition and a transient receptor potential type I (TRPV1) receptor antagonist each contain, as an active ingredient, at least one of the compound, a salt of the compound, and a solvate of the compound or the salt.

Abstract: A compound represented by formula (I?): (wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R1 represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group, an NO2 group, or the like; R2 represents halogen, amino, a hydrocarbon group, an aromatic heterocyclic group, or an oxo group; X1 represents O, —NR3—, or —S(O)r-; X2 represents a methylene group, O, —NR3—, or —S(O)r-; Q? represents a heteroaryl group, a heteroarylalkyl group, a substituted aryl group, or an aralkyl group; Cycle moiety represents an aryl ring or a heteroaryl ring; and the wavy line represents an E-isomer or a Z-isomer), a salt of the compound, or a solvate of the compound or the salt. A pharmaceutical composition and a transient receptor potential type I (TRPV1) receptor antagonist each contain, as an active ingredient, at least one of the compound, a salt of the compound, and a solvate of the compound or the salt.

Abstract: A compound represented by formula (I?): (wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R1 represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group, an NO2 group, or the like; R2 represents halogen, amino, a hydrocarbon group, an aromatic heterocyclic group, or an oxo group; X1 represents O, —NR3—, or —S(O)r-; X2 represents a methylene group, O, —NR3—, or —S(O)r-; Q? represents a heteroaryl group, a heteroarylalkyl group, a substituted aryl group, or an aralkyl group; Cycle moiety represents an aryl ring or a heteroaryl ring; and the wavy line represents an E-isomer or a Z-isomer), a salt of the compound, or a solvate of the compound or the salt. A pharmaceutical composition and a transient receptor potential type I (TRPV1) receptor antagonist each contain, as an active ingredient, at least one of the compound, a salt of the compound, and a solvate of the compound or the salt.

Abstract: In order to provide a hinge device exhibiting a latchless function even if a lock mechanism exposed on respective surfaces of a main body and a lid body is abolished and a small-sized electronic equipment using the same, the present invention is a hinge device coupling the main body and the lid body in a turnable manner in an open/close direction and a direction perpendicular to it, in which the hinge device includes a mounting member and supporting member to be mounted to either the main body or the lid body; a horizontal shaft member mounted to the mounting member and having a locking groove at an outer periphery thereof; an orthogonal shaft member mounted to the supporting member and having an engaging groove at an outer periphery thereof, the orthogonal shaft groove being orthogonal to the horizontal shaft member; a bracket member mounted to the horizontal shaft member and the orthogonal shaft member to allow the main body and the lid body to turn in the open/close direction and the direction perpendicula

Abstract: In a switching power supply circuit, completion of discharging of a capacitance provided in a soft-start circuit requires a period longer than a cycle with which an activating/deactivating portion switches switching control operation of a driving portion (which performs switching control to turn on/off a switching device provided in a stepping-up DC-DC converter) between an activated state and a deactivated state. Moreover, the soft-start circuit is prevented from performing soft-start operation until discharging of the capacitance is completed.

Abstract: A power supply circuit (10) has a current control portion (5) that controls, at a predetermined level, the currents passed through LEDs (3) and (4); a current setting portion (6) that sets, in the current control portion (5), the level of currents to be passed through the LEDs (3) and (4); and a checking portion (7) that checks whether or not currents at the current level set by the current setting portion (6) can be passed through the LEDs (3) and (4). The checking portion (7), on recognizing a condition in which at least one of the LEDs (3) and (4) cannot be fed with a current at the level set by the current setting portion (6), feeds the current setting portion (6) with a signal indicating the condition; on receiving the signal, the current setting portion (6) changes the currently set current level to a current level at which currents can be passed through both the LEDs (3) and (4).

Abstract: The voltage booster type switching power supply circuit is provided with a drive circuit for controlling a switching element, a start/stop circuit for turning the drive circuit on and off according to a brightness control signal for adjusting a brightness of a light source of a liquid crystal display device, an output voltage detection circuit for detecting whether the output voltage is greater than a predetermined voltage and feeding out a result as a comparison result signal, and a soft-start circuit that does not operate when the comparison result signal is active on the rising edge of the brightness control signal, and that operates so as to increase the output voltage gradually when the comparison result signal is inactive on the rising edge of the brightness control signal.

Abstract: In an optical recording method and apparatus for an optical storage medium, a recording pulse pattern having a sequence of multiple pulses is used to record one of plural kinds of marks with different lengths on the storage medium through a variable-linear-velocity recording process or a constant-angular-velocity recording process. Two or more discrete write powers are individually allocated to the respective pulses of the recording pulse pattern. Each of the write powers, allocated to the respective pulses of the recording pulse pattern, is linearly varied in proportion with a change of one of the recording linear velocity and a recording position of the storage medium. The resulting recording pulse pattern is supplied to a pickup, and the pickup emits a light beam to the storage medium in accordance with the recording pulse pattern having the linearly varied write powers allocated to the respective pulses, so that one of the plural kinds of marks is recorded on the storage medium.

Abstract: In a switching power supply circuit, completion of discharging of a capacitance provided in a soft-start circuit requires a period longer than a cycle with which an activating/deactivating portion switches switching control operation of a driving portion (which performs switching control to turn on/off a switching device provided in a stepping-up DC-DC converter) between an activated state and a deactivated state. Moreover, the soft-start circuit is prevented from performing soft-start operation until discharging of the capacitance is completed.

Abstract: A hinge for small electronic equipment has a latchless function even without a lock mechanism and couples the main and lid bodies in a turnable manner in vertical and horizontal directions. The hinge includes a mounting member and supporting member mounted to either the main or lid body, a horizontal shaft member mounted to the mounting member and having a locking groove, and an orthogonal shaft member mounted to the supporting member and having an engaging groove. The orthogonal shaft groove is orthogonal to the horizontal shaft member and a bracket member is mounted to the horizontal shaft member and the orthogonal shaft member to allow the main body and the lid body to turn in the vertical and horizontal directions. A restriction mechanism having a restriction pin is engaged with either the locking groove or the engaging groove.